AARTIDRUGS · Aarti Drugs Ltd · Biotechnology & Drugs
Last close, 30 Oct
Conditions Reading. Weighted summary of 8 measured readings. Not a rating of the stock and not a forecast.
Reading as of 30 Oct 2026 close
52-week range
18.5% below 52-week high
52-week range: as of 30 Oct 2026.
Slowest input: promoter pledge (disclosed quarterly), as of 18 Jul 2026
AI Summary
AI-generatedThe stock experienced a trend of 12.33% over the last 10 days, with 2 sessions above the 20-day moving average. The delivery percentage was 7.7%, significantly below the 20-day average of 47.1%, and the volume ratio over the last 5 days was 14.53. There was a conflict as the price rose while delivery stayed below its 20-day average.
Why did this change?
AARTIDRUGS's Conditions Reading eased from 71 to 70 today (-1).
- ▼Price trend: Trend reading weakened vs yesterday
- ▲Volume participation: volume participation increased
- ▲Delivery participation: delivery participation strengthened
- ▼Momentum (RSI): RSI moved lower
- ▼Sector standing: industry standing weakened
- –Promoter pledge: promoter pledge unchanged
- –Insider activity: insider filings unchanged
- –FII flow context: FII flow backdrop unchanged
▲ improved · ▼ weakened · – unchanged
The data shows the change but not its cause — several explanations are usually possible.
Tension in the data
AI-generated- ⚡ Price rose 10.7% over 10 sessions while delivery stayed below its 20-day average (23% vs 46%).
What the data shows
- Trend (10d)
- Sector standing
- Delivery (previous session)
- FII flow (5d)
- PCR
- Not available
- RSI (14)
- Promoter pledge
- Insider activity (30d)
- Event risk (5d)
Data as of 30 Oct 2026
Data as of 30 Oct 2026
Data as of 29 Oct 2026
Data timestamp unavailable
Data timestamp unavailable
Data as of 30 Oct 2026
Data as of 18 Jul 2026
Data timestamp unavailable
Data timestamp unavailable
Analyst checklist
- Trend
- Price rose 10.73% over the last 10 sessions.
- Volume confirmation
- Volume ran 14.68x the 5-day average — elevated participation.
- Delivery quality
- Delivery fell to 22.6% vs a 45.5% 20-day average.
- Sector standing
- Ranks #10 of 121 stocks measured in Biotechnology & Drugs today.
- Event risk
- No AI-classified news event matched this stock in the last 5 days.
- Growth trend
- Revenue grew 19.01% YoY last quarter (no multi-quarter acceleration streak on file).
- Valuation vs peers
- Trailing P/E of 18.05 sits below the sector average of 36.32.
Signal Change Log
- 29 Oct-4delivery signal weakened
- 29 Oct-4sector state cleared (sector strong no longer applied)
- 28 Oct+1510-day trend turned positive
- 28 Oct+15volume ran above its recent norm
- 28 Oct+15sector moved into the top ranks
- 28 Oct+15trend state cleared (below 20dma no longer applied)
- 28 Oct+15delivery state cleared (delivery up no longer applied)
- 27 Oct+6trend state cleared (trend down 10d no longer applied)
- 26 Oct+11delivery signal strengthened
- 26 Oct+11rsi state cleared (rsi oversold zone no longer applied)
- 23 Oct+4volume state cleared (volume muted no longer applied)
- 22 Oct+9RSI entered its lower zone
- 22 Oct+9fii state cleared (fii sell streak no longer applied)
- 21 Oct-9Conditions Reading eased 9 points on shifts across underlying measured values
- 19 Oct-3Conditions Reading eased 3 points on shifts across underlying measured values
- 16 Oct+5Conditions Reading rose 5 points on shifts across underlying measured values
- 15 Oct-3Conditions Reading eased 3 points on shifts across underlying measured values
- 14 Oct+7volume fell below its recent norm
- 13 Oct-3price held below its 20-day average
- 12 Oct-3Conditions Reading eased 3 points on shifts across underlying measured values
- 09 Oct-3Conditions Reading eased 3 points on shifts across underlying measured values
- 08 Oct+410-day trend turned negative
- 07 Oct-13Conditions Reading eased 13 points on shifts across underlying measured values
- 06 Oct-2trend state cleared (trend down 10d no longer applied)
- 06 Oct-2volume state cleared (volume elevated no longer applied)
- 05 Oct-710-day trend turned negative
- 01 Oct-7trend state cleared (above 20dma no longer applied)
- 30 Sept+4Conditions Reading rose 4 points on shifts across underlying measured values
Chart (3M daily)
Accent line: delivery % (last 21 sessions).
Related news
No related news.